injectable ghk-cu dosage recommendations topical GHK-Cu Peptide GHK-Cu Peptides Before and After:

These are the same formulas used in laboratory and clinical research settings

Why it was included in the FDA ban The FDA cites risk for immunogenicity, peptide-related impurities, and limited safety-related information as reasons for the BPC-157 ban

Cholesterol levels are a significant risk factor for atherosclerosis, as demonstrated by a study by Habas and Shang (106), which found that copper deficiency elevated cholesterol levels and impacted lipid metabolism thereby influencing the development of atherosclerosis (107)

Topical Peptides (Skincare) Topical peptides are well-established and generally considered safe